The physical basis of how prion conformations determine strain phenotypes

被引:483
作者
Tanaka, Motomasa
Collins, Sean R.
Toyama, Brandon H.
Weissman, Jonathan S. [1 ]
机构
[1] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA
[2] Calif Inst Quantitat Biomed Res, San Francisco, CA 94143 USA
[3] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan
基金
美国国家卫生研究院; 日本学术振兴会;
关键词
D O I
10.1038/nature04922
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
A principle that has emerged from studies of protein aggregation is that proteins typically can misfold into a range of different aggregated forms. Moreover, the phenotypic and pathological consequences of protein aggregation depend critically on the specific misfolded form(1,2). A striking example of this is the prion strain phenomenon, in which prion particles composed of the same protein cause distinct heritable states(3). Accumulating evidence from yeast prions such as [PSI+] and mammalian prions argues that differences in the prion conformation underlie prion strain variants(3-7). Nonetheless, it remains poorly understood why changes in the conformation of misfolded proteins alter their physiological effects. Here we present and experimentally validate an analytical model describing how [PSI+] strain phenotypes arise from the dynamic interaction among the effects of prion dilution, competition for a limited pool of soluble protein, and conformation-dependent differences in prion growth and division rates. Analysis of three distinct prion conformations of yeast Sup35 ( the [PSI+] protein determinant) and their in vivo phenotypes reveals that the Sup35 amyloid causing the strongest phenotype surprisingly shows the slowest growth. This slow growth, however, is more than compensated for by an increased brittleness that promotes prion division. The propensity of aggregates to undergo breakage, thereby generating new seeds, probably represents a key determinant of their physiological impact for both infectious ( prion) and non-infectious amyloids.
引用
收藏
页码:585 / 589
页数:5
相关论文
共 30 条
[1]   Prion generation in vitro:: amyloid of Ure2p is infectious [J].
Brachmann, A ;
Baxa, U ;
Wickner, RB .
EMBO JOURNAL, 2005, 24 (17) :3082-3092
[2]   Interactions among prions and prion "strains" in yeast [J].
Bradley, ME ;
Edskes, HK ;
Hong, JY ;
Wickner, RB ;
Liebman, SW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 :16392-16399
[3]   In vitro generation of infectious scrapie prions [J].
Castilla, J ;
Saá, P ;
Hetz, C ;
Soto, C .
CELL, 2005, 121 (02) :195-206
[4]   Protofibrils, pores, fibrils, and neurodegeneration: Separating the responsible protein aggregates from the innocent bystanders [J].
Caughey, B ;
Lansbury, PT .
ANNUAL REVIEW OF NEUROSCIENCE, 2003, 26 :267-298
[5]   Prion diseases of humans and animals: Their causes and molecular basis [J].
Collinge, J .
ANNUAL REVIEW OF NEUROSCIENCE, 2001, 24 :519-550
[6]   Mechanism of prion propagation: Amyloid growth occurs by monomer addition [J].
Collins, SR ;
Douglass, A ;
Vale, RD ;
Weissman, JS .
PLOS BIOLOGY, 2004, 2 (10) :1582-1590
[7]  
Cox B, 2003, GENETICS, V165, P23
[8]   Origins and kinetic consequences of diversity in Sup35 yeast prion fibers [J].
DePace, AH ;
Weissman, JS .
NATURE STRUCTURAL BIOLOGY, 2002, 9 (05) :389-396
[9]  
Derkatch IL, 1996, GENETICS, V144, P1375
[10]   Protein folding and misfolding [J].
Dobson, CM .
NATURE, 2003, 426 (6968) :884-890